Company profilePharmaceutical#1045 of 1,318 in Pakistan✓ No DRAP alerts

HSS

Pharmaceutical company · 3 brands · 4 molecules

Ranked #12 of 17 companies in Vaccine

3 registered products 4 pharmaceutical brands 4 distinct molecules 0 DRAP alerts

Company overview

3
registered products
4
pharmaceutical brands
4
distinct molecules
1
therapeutic classes
0
DRAP alerts

HSS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 3 product registrations across 4 distinct molecules. Its portfolio is concentrated in Vaccine. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Anti-Rabies Vaccine1 brand

Therapeutic classes

Vaccine · 2

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

GENE-TECH LABORATORIES3 shared molecules
HAKIMSONS IMPEX (PVT) LTD.3 shared molecules
SIND MEDICAL STORES3 shared molecules
NOVARTIS PHARMA (PAK) LTD2 shared molecules
AMSON2 shared molecules
SCOTMANN PHARMACEUTICALS1 shared molecules

Get the full profile for HSS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.